AQR Arbitrage’s Revance Therapeutics, Inc. RVNC Stock Holding History

AQR Arbitrage’s Portfolio RVNC Stock Details RVNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,413,103	Closed	-$4.3M	–	499
2024 Q4	$4.3M	Hold	1,413,103	–	–	0.09%	190
2024 Q3	$7.33M	Buy	+1,413,103	New	+$7.02M	0.16%	159

Other funds holding RVNC

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AQR Arbitrage's RVNC Position: Q1 2025 in Review

AQR Arbitrage sold out of Revance Therapeutics, Inc. (RVNC) in Q1 2025, closing a stake of 1,413,103 shares — an estimated $4.3M sold.

AQR Arbitrage first reported a position in RVNC in Q3 2024 and held it in 2 quarters. The position peaked at $7.33M in Q3 2024. 1 fund tracked by Wall St. Rank holds RVNC as of Q1 2025.

AQR Arbitrage reported no remaining Revance Therapeutics, Inc. position as of Q1 2025 after selling out during the quarter.
AQR Arbitrage sold 1,413,103 Revance Therapeutics, Inc. shares in Q1 2025, an estimated $4.3M.
AQR Arbitrage first reported a position in Revance Therapeutics, Inc. in Q3 2024 and held it in 2 quarters.
AQR Arbitrage's Revance Therapeutics, Inc. position peaked at $7.33M in Q3 2024.
1 fund tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q1 2025.

Based on AQR Arbitrage's 13F filing for Q1 2025, filed 15 May 2025.